The miR-221/222-Reck-Notch1 axis not only represents a vital epigenetic mechanism in regulating CSC self-renewal and maintenance, but also provides potential targets for inhibition of CSCs in treatment of SCLC. Here, RECK is linked to small cell lung carcinoma.